296 related articles for article (PubMed ID: 10783226)
1. Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.
Suwa M; Ito T; Kobashi A; Yagi H; Terasaki F; Hirota Y; Kawamura K
Am Heart J; 2000 May; 139(5):905-12. PubMed ID: 10783226
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications derived from ultrasonic tissue characterization with myocardial integrated backscatter in patients with dilated cardiomyopathy.
Suwa M; Ito T; Nakamura T; Miyazaki S
Int J Cardiol; 2002 Aug; 84(2-3):133-40. PubMed ID: 12127365
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonic tissue characterization in patients with dilated cardiomyopathy: comparison with findings from right ventricular endomyocardial biopsy.
Fujimoto S; Mizuno R; Nakagawa Y; Kimura A; Yamaji K; Yutani C; Dohi K; Nakano H
Int J Card Imaging; 1999 Oct; 15(5):391-6. PubMed ID: 10595405
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: value in noninvasive assessment of myocardial fibrosis.
Naito J; Masuyama T; Mano T; Kondo H; Yamamoto K; Nagano R; Doi Y; Hori M; Kamada T
Am Heart J; 1996 Jan; 131(1):115-21. PubMed ID: 8553997
[TBL] [Abstract][Full Text] [Related]
5. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.
Suwa M; Otake Y; Moriguchi A; Ito T; Hirota Y; Kawamura K; Adachi I; Narabayashi I
Am Heart J; 1997 Mar; 133(3):353-8. PubMed ID: 9060806
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonic tissue characterization can predict beta-blocker efficacy in dilated cardiomyopathy.
Kondo I; Mizushige K; Nozaki S; Iwado Y; Hirao K; Senda S; Kohno M; Matsuo H
Ultrasound Med Biol; 2001 Aug; 27(8):1079-86. PubMed ID: 11527594
[TBL] [Abstract][Full Text] [Related]
7. Serial measurement of integrated ultrasonic backscatter in human cardiac allografts for the recognition of acute rejection.
Masuyama T; Valantine HA; Gibbons R; Schnittger I; Popp RL
Circulation; 1990 Mar; 81(3):829-39. PubMed ID: 2306834
[TBL] [Abstract][Full Text] [Related]
8. Myocardial ultrasonic tissue characterization for estimating histological abnormalities in hypertrophic cardiomyopathy: comparison with endomyocardial biopsy findings.
Mizuno R; Fujimoto S; Yamaji K; Yutani C; Hashimoto T; Nakamura S
Cardiology; 2001; 96(1):16-23. PubMed ID: 11701936
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive quantitation of myocardial fibrosis using combined tissue harmonic imaging and integrated backscatter analysis in dilated cardiomyopathy.
Mizuno R; Fujimoto S; Saito Y; Nakamura S
Cardiology; 2007; 108(1):11-7. PubMed ID: 16960443
[TBL] [Abstract][Full Text] [Related]
10. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint.
Yamada T; Fukunami M; Ohmori M; Iwakura K; Kumagai K; Kondoh N; Minamino T; Tsujimura E; Nagareda T; Kotoh K
J Am Coll Cardiol; 1993 Mar; 21(3):628-33. PubMed ID: 8094721
[TBL] [Abstract][Full Text] [Related]
11. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
12. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
[TBL] [Abstract][Full Text] [Related]
13. Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias.
Limongelli G; Pacileo G; Cerrato F; Verrengia M; Di Simone A; Severino S; Sarubbi B; Calabrò R
J Am Soc Echocardiogr; 2003 Aug; 16(8):803-7. PubMed ID: 12878988
[TBL] [Abstract][Full Text] [Related]
14. Beta-Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy.
Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H
J Am Heart Assoc; 2021 Jun; 10(12):e019240. PubMed ID: 34053244
[TBL] [Abstract][Full Text] [Related]
15. Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Slart RH; Tio RA; van der Vleuten PA; Willems TP; Lubbers DD; Dierckx RA; van Veldhuisen DJ
J Nucl Cardiol; 2010 Jun; 17(3):479-85. PubMed ID: 20238193
[TBL] [Abstract][Full Text] [Related]
16. Influence of propranolol infusion on cyclic variation of myocardial integrated backscatter in hypertrophic obstructive cardiomyopathy.
Ito T; Suwa M; Kobashi A; Nakamura T; Miyazaki S; Imai M; Kitaura Y
J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 2):1251-5. PubMed ID: 12411913
[TBL] [Abstract][Full Text] [Related]
17. Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy.
Ito T; Hoshida S; Nishino M; Aoi T; Egami Y; Takeda T; Kawabata M; Tanouchi J; Yamada Y; Kamada T
Eur J Nucl Med; 2001 Dec; 28(12):1811-6. PubMed ID: 11734920
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
[TBL] [Abstract][Full Text] [Related]
19. Myocardial scintigraphy using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to beta-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect.
Yoshinaga K; Tahara M; Torii H; Akimoto M; Kihara K; Tei C
J Cardiol; 2000 May; 35(5):343-51. PubMed ID: 10834178
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
Hara Y; Inoue K; Ogimoto A; Ohtsuka T; Shigematsu Y; Nakata S; Higaki J
Cardiology; 2005; 104(1):16-21. PubMed ID: 15942178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
